# Efficacy and Safety Between Tegileridine and Sufentanil in Laparoscopic Surgery Patients at High Risk of Postoperative Nausea and Vomiting

> **NCT07691086** · — · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, Zhejiang University, School of Medicine** · enrollment: 800 (estimated)

## Conditions studied

- Postoperative Nausea and Vomiting (PONV)
- Enhanced Recovery After Surgery
- Laparoscopic Surgery

## Interventions

- **DRUG:** analgesic drugs and methods

## Key facts

- **NCT ID:** NCT07691086
- **Lead sponsor:** Second Affiliated Hospital, Zhejiang University, School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691086, "Efficacy and Safety Between Tegileridine and Sufentanil in Laparoscopic Surgery Patients at High Risk of Postoperative Nausea and Vomiting". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*